000 01342 a2200373 4500
005 20250513113919.0
264 0 _c19970723
008 199707s 0 0 eng d
022 _a0924-977X
024 7 _a10.1016/s0924-977x(96)00041-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiller, C H
245 0 0 _aRisk factors for the development of neuroleptic induced akathisia.
_h[electronic resource]
260 _bEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
_cFeb 1997
300 _a51-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAkathisia, Drug-Induced
_xdiagnosis
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInpatients
650 0 4 _aMale
650 0 4 _aProspective Studies
650 0 4 _aRisk Factors
650 0 4 _aSchizophrenia
_xcomplications
700 1 _aHummer, M
700 1 _aOberbauer, H
700 1 _aKurzthaler, I
700 1 _aDeCol, C
700 1 _aFleischhacker, W W
773 0 _tEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
_gvol. 7
_gno. 1
_gp. 51-5
856 4 0 _uhttps://doi.org/10.1016/s0924-977x(96)00041-7
_zAvailable from publisher's website
999 _c9072694
_d9072694